Head of Strategic Planning
BridgeBio · Palo Alto County, IA · 1 mo ago
$335k–$370k/yrFull-time
About the role
The Head of Strategic Planning will partner directly with the Chief Strategy Officer & Chief Legal Officer to shape the corporate strategy of one of the most productive rare disease companies in the industry. This is a role for someone who thinks rigorously, communicates with precision, and brings the kind of structured, first-principles thinking that turns complexity into clarity for a Board, a CEO, or an affiliate head trying to make a critical decision.
Responsibilities
- Strategy at BridgeBio is not a support function. It is the connective tissue between where we are and where we are going.
- Lead the development and ongoing management of BridgeBio’s long-range strategic plan, translating the company’s mission, pipeline, and commercial trajectory into a rigorous, dynamic view of where the company is going and how it gets there.
- Own the annual strategic planning process: designing the framework, aligning cross-functional leadership, and producing the outputs that guide resource allocation and prioritization.
- Drive goal-setting and operational planning processes (including OKRs or equivalent frameworks) that connect enterprise strategy to affiliate and functional execution.
- Identify and frame the most important strategic questions facing the company, and bring structured thinking and rigorous analysis to answering them.
- Pipeline & Affiliate Prioritization: Partner with R&D, Regulatory, Commercial, affiliate leadership, and other relevant functional teams in the firm’s efforts to evaluate and prioritize the pipeline, helping the company make clear-eyed decisions about where to invest, accelerate, and where to make harder calls.
- Build and maintain analytical frameworks that allow leadership to assess portfolio risk, opportunity, and strategic fit with clarity and consistency.
- Support affiliate leadership in developing and stress-testing their own strategic plans, ensuring alignment with enterprise priorities.
- Strategic Intelligence & External Landscape: Synthesize external signals into strategic implications: scientific advances, competitor pipeline developments, regulatory shifts, and market dynamics that could reshape BridgeBio’s position or sequencing decisions.
- Work in close partnership with Business Development and Operations to supplement and add additional strategic considerations in connection with competitive intelligence, adding a distinct layer of strategic synthesis and enterprise-level framing.
- Ensure the company is never surprised by a development it should have seen coming. Maintain a forward view of geopolitical, governmental, and market dynamics that could affect the business.
- Partnerships & Strategic Transactions: When relevant, support the teams’ evaluation of potential licensing deals, strategic partnerships, and transactions, bringing strategic clarity and insight to how opportunities are assessed against portfolio priorities.
- Develop frameworks for evaluating business development opportunities against portfolio strategy and resource priorities.
- Partner with Legal, Finance, and R&D on diligence and planning for strategic transactions where they arise.
- Board & Investor-Facing Strategy Materials: Lead the development of Board-level strategy presentations, long-range strategic plans, and other materials that communicate BridgeBio’s strategic direction with clarity and conviction.
- Partner with Strategic Finance (incl. IR) and the executive team to ensure investor-facing communications reflect the company’s strategic narrative accurately and compellingly.
- Bring the highest standards of analytical rigor and communication quality to every materials package that goes to a Board member or external stakeholder.
Qualifications
- 8 to 12+ years of experience in strategic planning, management consulting, or investment banking, with meaningful exposure to the biopharmaceutical or life sciences sector.
- Experience at a top-tier strategy firm (McKinsey, BCG, Bain or equivalent) is strongly preferred.
- Substantive biotech or pharma industry experience, understanding pipeline assets, competitive dynamics, and credible long-range strategic plans.
- Analytical exceptionalism, comfortable with financial modeling, scenario analysis, and the quantitative underpinning of strategic decisions.
- Communicates with precision and economy, writes and speaks clearly, knows when to use a slide and when to use a conversation, and never confuses activity with insight.
- Collaborated across functions, R&D, Commercial, Finance, Legal, and built trust with people who have different priorities and different fluencies.
- Advanced degree is strongly preferred: MBA, PhD, MD, or equivalent.